Pfizer’s Xeljanz scores EU approval for active psoriatic arthritis
June 29, 2018Medical Communications, Sales and Marketing EU, Europe, Pfizer, Xeljanz, pharma, psoriatic arthritis
Pfizer has announced that the European Commission (EC) has approved Xeljanz in combination with methotrexate (MTX) for the treatment of …
NICE turns down Roche’s Ocrevus in early primary progressive multiple sclerosis
June 29, 2018Medical Communications, Sales and Marketing NICE, Ocrevus, Roche, pharma
Roche’s sometimes strained relationship with NICE continues as the health watchdog for England and Wales chose to reject the former’s …
Amazon makes first move into healthcare with online pharmacy acquisition
June 28, 2018Medical Communications, Sales and Marketing amazon, pharma, pharmacy
It’s been thought to have been on the cards for some time, but now, after much speculation, retail giant Amazon …
Ferring’s heat-stable drug could stop post-childbirth bleeding, WHO says
June 28, 2018Research and Development Carbetocin, Ferring Pharmaceuticals, MSD, WHO, childbirth, pharma
A new formulation of a drug to prevent excessive bleeding in women after childbirth could save thousands of lives, says …
Centralised EMR systems drive patient-physician relationships, report indicates
June 28, 2018Medical Communications, Research and Development Electronic Medical Records, pharma
Advancement of IT within healthcare is transforming the dynamics of the patient-physician relationship and it is important to integrate various …
Summit Pharma axes Duchenne drug after Phase 2 failures
June 28, 2018Research and Development Duchenne Muscular Dystrophy, Summit Pharmaceuticals, pharma, trial failure
Summit Therapeutics has revealed it is to terminate development of its Duchenne muscular dystrophy (DMD) drug ezutromid after it failed …
Roche’s Alecensa secures NICE approval in NSCLC after topping Pfizer’s Xalkori
June 28, 2018Sales and Marketing Alecensa, NICE, NSCLC, Pfizer, Xalkori, pharma
UK health watchdog NICE has given its approval for Roche’s selective ALK inhibitor Alecensa (alectinib) for use on the NHS, …
Amgen biosimilar proves non-inferior to J&J’s Remicade in rheumatoid arthritis
June 27, 2018Research and Development, Sales and Marketing Amgen, Johnson & Jonson, Remicade, pharma, rheumatoid arthritis
Amgen has unveiled new Phase 3 data for its biosimilar version of Johnson & Johnson’s Remicade (infliximab), confirming that it …
US hospital’s ketamine study forced to a halt over consent concerns
June 27, 2018Research and Development Hennepin Healthcare, Ketamine, pharma
Minneapolis-based hospital Hennepin County Medical Center has put the brakes on a clinical trial investigating the efficacy of ketamine in …
Abbvie and Google’s Calico extend age-related disease partnership to $2.5bn
June 27, 2018Research and Development, Sales and Marketing AbbVie, Cancer, Goggle, calico, pharma
The partnership of Abbvie and Google’s Calico has announced they are to extend their existing 10-year drug discovery and development …
AstraZeneca’s Lynparza proves efficacy in first-line BRCA-mutated advanced ovarian cancer
June 27, 2018Research and Development, Sales and Marketing AstraZeneca, Cancer, MSD, Merck, ovarian cancer, pharma
AstraZeneca is celebrating alongside partner MSD with the reveal of new data on the use of Lynparza in the first-line …
FDA panels vote to reject Pain Therapeutics’ abuse-deterrent opioid drug
June 27, 2018Research and Development, Sales and Marketing Remoxy, opioid crisis, opioids, pain therapeutics, pharma
Drug development firm Pain Therapeutics has revealed that its abuse-deterrent opioid medication Remoxy has been rejected by an FDA advisory …
Roivant launches two new companies amid major restructure and staff layoffs
June 26, 2018Manufacturing and Production, Research and Development Roivant, pharma
Roivant, the global biopharmaceutical firm spearheaded by founder and CEO Vivek Ramaswamy (pictured), has announced it is to undergo a …
Boehringer injects €230 million in new Biologicals Development Center
June 26, 2018Manufacturing and Production Boehringer Ingelheim, biologics, manufacturing, pharma
Prominent industry player Boehringer Ingelheim has unveiled plans to invest €230 million into the construction of a new Biologicals Development …
NHS “below average” in treating eight most common causes of death, report says
June 26, 2018Manufacturing and Production, Medical Communications NHS, pharma
The NHS’s 70th birthday is again marked as a bittersweet one as a new report from the Nuffield Trust highlights …
Pfizer’s Ibrance combo fails to improve overall survival in HER2- metastatic breast cancer
June 26, 2018Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, Faslodex, Pfizer, breast cancer, ibrance, pharma
Pfizer has stumbled with the reveal of new data on the efficacy of its oral CDK 4/6 inhibitor Ibrance (palbociclib) in combination …
Sanofi’s Toujeo proves non-inferior to insulin degludec in type 2 diabetes
June 26, 2018Manufacturing and Production, Research and Development, Sales and Marketing American Diabetes Association, Sanofi, diabetes, insulin glargine, pharma, toujeo, type 2 diabetes
Sanofi took the opportunity at the American Diabetes Association (ADA) 78th Scientific Sessions in Florida to unveil new data on …
GW Pharma’s Epidiolex becomes first cannabis-based medicine available in US
June 26, 2018Manufacturing and Production, Sales and Marketing FDA, GW Pharma, Lennox-Gastaut syndrome, UK, US, cannabidiol, cannabis
In what could prove to be a pivotal decision, UK biotech GW Pharmaceuticals has announced that its oral cannabidiol solution …
Working Life: Vertex Pharma’s Simon Lem, VP, Regional General Manager of North Europe
June 25, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Vertex, Vertex pahrma, Working Life, feature, pharma
Pharmafocus caught up with Vertex Pharma’s Simon Lem to discuss his journey throughout the industry and the importance of the …
European Commission greenlights Gilead’s Biktarvy for HIV-1
June 25, 2018Sales and Marketing Biktarvy, EU, Europe, European Commission, HIV, HIV-1, pharma
Good news for Gilead and HIV patients across the European Union today as the prominent pharma firm announced that its …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
